Phthalate exposure associated with self-reported diabetes among Mexican women

Environmental Research

Volumn 111, Issue 6, 2011, Pages 792-796

  Svensson, Katherine ^a,b   Hernández Ramírez, Raúl U ^b   Burguete García, Ana ^b   Cebrián, Mariano E ^c   Calafat, Antonia M ^d   Needham, Larry L ^d   Claudio, Luz ^e   López Carrillo, Lizbeth ^b  

^a UNIVERSITY OF PUERTO RICO   (Puerto Rico)

^b INSTITUTO NACIONAL DE SALUD PÚBLICA   (Mexico)

^c Departamento de Toxicologa   (Mexico)

^d NATIONAL CENTER FOR ENVIRONMENTAL HEALTH   (United States)

^e MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Diabetes; Environmental health; Mexico; Phthalates; Urinary metabolites

Indexed keywords

PHTHALIC ACID;

CANCER; DIABETES; HEALTH IMPACT; HEALTH SURVEY; HOMEOSTASIS; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; METABOLISM; METABOLITE; PHTHALATE; PLASTIC; POLLUTION EXPOSURE; POLYMER; URINE; WOMENS HEALTH;

ADULT; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; ENVIRONMENTAL EXPOSURE; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; MEXICO; PRIORITY JOURNAL; SELF REPORT; SOLID PHASE EXTRACTION; TANDEM MASS SPECTROMETRY; URINALYSIS;

CROSS-SECTIONAL STUDIES; DIABETES MELLITUS; FEMALE; HUMANS; MEXICO; MIDDLE AGED; PHTHALIC ACIDS;

MEXICO [NORTH AMERICA];

EID: 79960626974     PISSN: 00139351     EISSN: 10960953     Source Type: Journal    
DOI: 10.1016/j.envres.2011.05.015     Document Type: Article

References (40)

1. Adibi J.J., Whyatt R.M., Williams P.L., Calafat A.M., Camann D., Herrick R., et al. Characterization of phthalate exposure among pregnant women assessed by repeat air and urine samples. Environ. Health Perspect. 2008, 116:467-473.
2. American Diabetes Association Diagnosis and classification of diabetes. Diabetes Care 2008, 31(suppl 1):S55-S60.
3. Aschner P. Metabolic syndrome as a risk factor for diabetes. Expert Rev. Cardiovasc. Ther. 2010, 8:407-412.
4. Agency for Toxic Substances and Disease Registry (ATSDR) Toxicological profile for diethyl phthalate (DEP) 1995, Agency for Toxic Substances and Disease Registry, Atlanta, GA, Accessed June 20, 2010: 〈http://www.atsdr.cdc.gov/toxprofiles/tp73-p.pdf.
5. Agency for Toxic Substances and Disease Registry (ATSDR) Toxicological profile for di-n-octyl phthalate (DNOP) 1997, Agency for Toxic Substances and Disease Registry, Atlanta, GA, Accessed June 20, 2010: 〈http://www.atsdr.cdc.gov/toxprofiles/tp95.pdf.
6. Agency for Toxic Substances and Disease Registry (ATSDR) Toxicological profile for di-n-butyl phthalate (DBP) 2001, Agency for Toxic Substances and Disease Registry, Atlanta, GA, Accessed June 20, 2010: 〈http://www.atsdr.cdc.gov/toxprofiles/tp135.pdf.
7. Agency for Toxic Substances and Disease Registry (ATSDR) Toxicological profile for di(2-ethylhexyl) phthalate (DEHP) 2002, Agency for Toxic Substances and Disease Registry, Atlanta, GA, Accessed June 20, 2010: 〈http://www.atsdr.cdc.gov/ToxProfiles/tp9.pdf.
8. Auwerx J. PPAR gamma, the ultimate thrifty gene. Diabetology 1999, 42:1033-1049.
9. Barr D.B., Wilder L.C., Caudill S.P., Gonzalez A.J., Needham L.L., Pirkle J.L. Urinary creatinine concentrations in the U.S. population: implications for urinary biologic monitoring measurements. Environ. Health Perspect. 2005, 113:192-200.
10. Bility M.T., Thompson J.T., McKee R.H., David R.M., Butala J.H., Vanden Heuvel J.P., Peters J.M. Activation of mouse and human peroxisome proliferator-activated receptors (PPARs) by phthalate monoesters. Toxicol. Sci. 2004, 82:170-182.
11. Boberg J., Metzdorff S., Wortziger R., Axelstad M., Brokken L., Vinggaard A.M., et al. Impact of diisobutyl phthalate and other PPAR agonists on steroidogenesis and plasma insulin and leptin levels in fetal rats. Toxicology 2008, 250(2-3):75-81.
12. Casals-Casas C., Feige J.N., Desvergne B. Interference of pollutants with PPARs: Endocrine disruption meets metabolism. Int. J. Obesity 2008, 32(Suppl 6):S53-S61.
13. Desvergne B., Feige J.N., Casals-Casas C. PPAR-mediated activity of phthalates: a link to the obesity epidemic?. Mol. Cell. Endocrinol. 2009, 304:43-48.
14. Feige J.N., Gelman L., Rossi D., Zoete V., Metivier R., Tudor C., et al. The endocrine disruptor monoethyl-hexyl-phthalate is a selective peroxisome proliferator-activated receptor gamma modulator that promotes adipogenesis. J. Biol. Chem. 2007, 282:19152-19166.
15. Feige J.N., Gerber A., Casals-Casas C., Yang Q., Winkler C., Bedu E., et al. The pollutant diethylhexyl phthalate regulates hepatic energy metabolism via species-specific PPARalpha-dependent mechanisms. Environ. Health Perspect. 2010, 118:234-241.
16. Fromme H., Bolte G., Koch H.M., Angerer J., Boehmer S., Drexler H., et al. Occurrence and daily variation of phthalate metabolites in the urine of an adult population. Int. J. Hyg. Environ. Health 2007, 210:21-33.
17. Gayathri N.S., Dhanya C.R., Indu A.R., Kurup P.A. Changes in some hormones by low doses of di (2-ethyl hexyl) phthalate (DEHP), a commonly used plasticizer in PVC blood storage bags & medical tubing. Indian J. Med. Res. 2004, 119:139-144.
18. Grün F., Blumberg B. Perturbed nuclear receptor signaling by environmental obesogens as emerging factors in the obesity crisis. Rev. Endocrine Metab. Disorders 2007, 8:161-171.
19. Hatch E.E., Nelson J.W., Querishi M.M., Weinberg J., Moore L.L., Stinger M., et al. Association of urinary phthalate metabolite concentration with body mass index and waist circumference: a cross-sectional study of NHANES data, 1999-2002. Environ. Health 2008, 3:27.
20. Hauser R., Calafat A.M. Phthalates and human health. Occupational Environ. Med. 2005, 62:806-818.
21. Hauser R., Meeker J.D., Park S., Silva M.J., Calafat A.M. Temporal variability of urinary phthalate metabolite levels in men of reproductive age. Environ. Health Perspect. 2004, 112:1734-1740.
22. Hauser R., Meeker J.D., Duty S., Silva M.J., Calafat A.M. Altered semen quality in relation to urinary concentrations of phthalate monoester and oxidative metabolites. Epidemiology 2006, 17:682-691.
23. Holemans K., Aerts L., Van Assche F.A. Lifetime consequences of abnormal fetal pancreatic development. J. Physiol. 2003, 547:11-20.
24. Hoppin J.A., Brock J.W., Davis B.J., Baird D.D. Reproducibility of urinary phthalate metabolites in first morning urine samples. Environ. Health Perspect. 2002, 110:515-518.
25. Hurst C.H., Waxman D.J. Activation of PPARalpha and PPARgamma by environmental phthalate monoesters. Toxicol. Sci.: An Official J. Soc. Toxicol. 2003, 74:297-308.
26. Kapoor D., Goodwin E., Channer K.S., Jones T.H. Testosterone replacement therapy improves insulin resistance, glycaemic control, visceral adiposity and hypercholesterolaemia in hypogonadal men with type 2 diabetes. Eur. J. Endocrinol. 2006, 154:899-906.
27. Kato K., Silva M.J., Needham L.L., Calafat A.M. Determination of 16 phthalate metabolites in urine using automated sample preparation and on-line preconcentration/high-performance liquid chromatography/tandem mass spectrometry. Anal. Chem. 2005, 77:2985-2991.
28. López-Carrillo L., Hernández-Ramírez R.U., Calafat A.M., Torres-Sánchez L., Galván-Portillo M., Needham L.L., et al. Exposure to phthalates and breast cancer risk in Northern Mexico. Environ. Health Perspect. 2010, 118:539-544.
29. Main K.M., Mortensen G.K., Kaleva M.M., Boisen K.A., Damgaard I.N., Chellakooty M., et al. Human breast milk contamination with phthalates and alterations of endogenous reproductive hormones in infants three months of age. Environ. Health Perspect. 2006, 114:270-276.
30. National Toxicology Program U.S Department of Health and Human Services. Center for the Evaluation of Risks to Human Reproduction, 2003. NTP-CERHR Mongraph on the Potential Human Reproductive and Developmental effects of Butyl Benzyl Phthalate (BBP). Accessed June 20, 2010: 〈. http://cerhr.niehs.nih.gov/chemicals/phthalates/bb-phthalate/BBP_Monograph_Final.pdf.
31. Olaiz-Fernández G., Rivera-Dommarco J., Shamah-Levy T., Rojas R., Villalpando-Hernández S., Hernández-Avila M., Sepúlveda-Amor J., Encuesta Nacional de Salud y Nutrición, 2006. Cuernavaca, México: Instituto Nacional de Salud Pública, 2006. Accessed May 28, 2010 from: 〈. http://www.insp.mx/ensanut/ensanut2006.pdf.
32. Pan G., Hanaoka T., Yoshimura M., Zhang S., Wang P., Tsukino H., et al. Decreased serum free testosterone in workers exposed to high levels of di-n-butyl phthalate (DBP) and di-2-ethylhexyl phthalate (DEHP): a cross-sectional study in China. Environ. Health Perspect. 2006, 114:1643-1648.
33. Peck J.D., Sweeney A.M., Symanski E., Gardiner J., Silva M.J., Calafat A.M., et al. Intra- and inter-individual variability of urinary phthalate metabolite concentrations in Hmong women of reproductive age. J. Expo. Sci. Environ. Epidemiol. 2010, 20:90-100.
34. Rengarajan S., Parthasarathy C., Anitha M., Balasubramanian K. Diethylhexyl phthalate impairs insulin binding and glucose oxidation in Chang liver cells. Toxicol. In Vitro 2007, 21:99-102.
35. Secretaria de Salud (SSA), 2005. Encuesta nacional de enfermedades crónicas. Mexico, DF. Accessed June 15, 2009, from: 〈. http://www.dgepi.salud.gob.mx/publicaciones/.
36. Stahlhut R.W., van Wijngaarden E., Dye T.D., Cook S., Swan S.H. Concentrations of urinary phthalate metabolites are associated with increased waist circumference and insulin resistance in adult U.S. males. Environ. Health Perspect. 2007, 115:876-882.
37. StataCorp Stata Statistical Software: Release 10 2005, StataCorp LP, College Station, TX.
38. Swan S.H. Environmental phthalate exposure in relation to reproductive outcomes and other health endpoints in humans. Environ. Res. 2008, 108:177-184.
39. Tapia-Conyer R., Gutierrez G., Sepulveda J. Methodology of the National Seroepidemiologic Survey, Mexico. Salud Pública Mex 1992, 34:124-135.
40. Teitelbaum S.L., Britton J.A., Calafat A.M., Ye X., Silva M.J., Reidy J.A., et al. Temporal variability in urinary concentrations of phthalate metabolites, phytoestrogens and phenols among minority children in the United States. Environ. Res. 2008, 106:257-269.